X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (9) 9
double-blind method (6) 6
abridged index medicus (5) 5
acute coronary syndrome - drug therapy (5) 5
clopidogrel (5) 5
follow-up studies (5) 5
acute coronary syndromes (4) 4
cardiac & cardiovascular systems (4) 4
medical and health sciences (4) 4
medicin och hälsovetenskap (4) 4
receptor, par-1 - antagonists & inhibitors (4) 4
risk (4) 4
aged (3) 3
cardiovascular (3) 3
cardiovascular disease (3) 3
clinical trials (3) 3
coronary heart disease (3) 3
drug therapy (3) 3
drug therapy, combination (3) 3
female (3) 3
heart attacks (3) 3
kaplan-meier estimate (3) 3
male (3) 3
middle aged (3) 3
myocardial infarction (3) 3
safety (3) 3
stroke (3) 3
thrombin (3) 3
vorapaxar (3) 3
acute coronary syndrome - blood (2) 2
administration, oral (2) 2
analysis (2) 2
anti-platelet agents (2) 2
antibodies, monoclonal - therapeutic use (2) 2
aspirin - administration & dosage (2) 2
blood platelets - drug effects (2) 2
cardiac and cardiovascular systems (2) 2
cardiovascular diseases (2) 2
cardiovascular diseases - mortality (2) 2
care and treatment (2) 2
cerebral infarction (2) 2
clinical medicine (2) 2
dosage and administration (2) 2
hematology (2) 2
hospitalization (2) 2
kardiologi (2) 2
klinisk medicin (2) 2
lactones - administration & dosage (2) 2
lactones - adverse effects (2) 2
lactones - therapeutic use (2) 2
medicine, general & internal (2) 2
myocardial infarction - prevention & control (2) 2
par-1 receptor (2) 2
peripheral vascular disease (2) 2
pharmacodyamics (2) 2
platelet aggregation inhibitors (2) 2
platelet aggregation inhibitors - therapeutic use (2) 2
pyridines - administration & dosage (2) 2
pyridines - adverse effects (2) 2
pyridines - therapeutic use (2) 2
receptors, thrombin - metabolism (2) 2
secondary prevention (2) 2
therapy (2) 2
thienopyridines (2) 2
thrombosis (2) 2
treatment outcome (2) 2
usage (2) 2
acute coronary syndrome (1) 1
acute coronary syndrome - complications (1) 1
acute coronary syndrome - physiopathology (1) 1
acute coronary syndrome - therapy (1) 1
adenosine diphosphate - metabolism (1) 1
adjudication (1) 1
administration, oral; cardiovascular diseases; diabetes mellitus, type 2; double-blind method; drug therapy, combination; follow-up studies; heart diseases; heart failure; hemoglobin a, glycosylated; hospitalization; humans; hypoglycemic agents; kaplan-meier estimate; pyrazines; sitagliptin phosphate; triazoles; medicine (1) 1
aggregation (1) 1
analysis and chemistry (1) 1
angina (1) 1
angina pectoris (1) 1
angina, unstable - prevention & control (1) 1
angioplasty (1) 1
antagonist (1) 1
antagonists (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, humanized (1) 1
anticholesteremic agents - therapeutic use (1) 1
antiplatelet therapy (1) 1
apolipoproteins b - blood (1) 1
artery-disease (1) 1
article (1) 1
aspirin (1) 1
aspirin - adverse effects (1) 1
association (1) 1
atherothrombotic events (1) 1
atorvastatin (1) 1
atorvastatin calcium (1) 1
biomarkers - blood (1) 1
biomarkers - metabolism (1) 1
bleeding (1) 1
blood (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 682 - 689.e1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 1, pp. 20 - 33
In this trial, vorapaxar, a protease-activated–receptor 1 antagonist that inhibits thrombin-induced platelet activation, was not effective in reducing the... 
MEDICINE, GENERAL & INTERNAL | PLACEBO | GLYCOPROTEIN IIB/IIIA INHIBITORS | CLOPIDOGREL | TASK-FORCE | SAFETY | DOUBLE-BLIND | ANTIPLATELET THERAPY | Follow-Up Studies | Angioplasty | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Combined Modality Therapy | Lactones - adverse effects | Lactones - therapeutic use | Acute Coronary Syndrome - drug therapy | Intracranial Hemorrhages - chemically induced | Coronary Artery Bypass | Acute Coronary Syndrome - therapy | Aged | Hemorrhage - chemically induced | Antagonists (Biochemistry) | Drugs | Dose-response relationship (Biochemistry) | Dosage and administration | Product/Service Evaluations | Drug therapy | Coronary heart disease | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Cardiovascular disease | Hemorrhage | Bleeding | Investigations | Manuscripts | Ischemia | Blood platelets | Acute coronary syndromes | Research centers | Malalties cardiovasculars | Bypass cardiopulmonar | Medicaments | Bypass cardiopulmonary | Plaquetes sanguínies | Cardiovascular diseases | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
by Ray, Kausik K and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Diaz, Rafael and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Loizeau, Virginie and Lopes, Renato D and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and Zeiher, Andreas M and Schwartz, Gregory G and Steg, Philippe Gabriel and Schwartz, Gregory G and Steg, Ph. Gabriel and Bhatt, Deepak L and Bittner, Vera A and Diaz, Rafael and Goodman, Shaun G and Harrington, Robert A and Jukema, J. Wouter and Szarek, Michael and White, Harvey D and Zeiher, Andreas M and Tricoci, Pierluigi and Roe, Matthew T and Mahaffey, Kenneth W and Edelberg, Jay M and Hanotin, Corinne and Lecorps, Guillaume and Moryusef, Angèle and Pordy, Robert and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Lopes, Renato D and Gotcheva, Nina N and Prieto, Juan-Carlos and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Takeshi and Kim, Hyo Soo and Kim, Sang-Hyun and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Budaj, Andrzej and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Ristic, Arsen D and Chua, Terrance and Murin, Jan and Fras, Zlatko and Dalby, Anthony J and Tuñón, José and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Ray, Kausik K and Moriarty, Patrick M and Vogel, Robert and ... and ODYSSEY OUTCOMES Committees and Investigators and ODYSSEY OUTCOMES Comm Investigato and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 113, Issue 6, pp. 936 - 944
Journal Article